HIV/AIDS
Ademio®
Registration certificate:
INN:
Lopinavir+Ritonavir
Release form:
Film-coated tablets
Therapeutic Area:
HIV/AIDS
Pharmacotherapeutic Group:
Direct-acting antivirals, Antiviral agents for systemic use, Antiviral [HIV] Agent
Conditions for dispensing:
On prescription
Packaging:

Indications for Use: Treatment of human immunodeficiency virus (HIV) infection in adults and children aged 3 years and older, as part of combination therapy.

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Ademio® (Lopinavir+Ritonavir), please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx

Quality control
at all stages of production